Jan G. J. van de Winkel

Genmab (United States) — United States

Medicine · Health Sciences

79h-index22.1kcitations316works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(232), Glycosylation and Glycoproteins Research(89), T-cell and B-cell Immunology(71), Immune Cell Function and Interaction(38), Cell Adhesion Molecules Research(32)

Publications315 total

Data from Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action
2023Open Access
Supplementary Figure 5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Legends of Tables 1-2, Figures 1-5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Materials and Methods from Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action
2023Open Access
Supplementary Figure 3 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Legends of Tables 1-2, Figures 1-5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Data from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 1 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Table 1 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Table 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Materials and Methods from Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action
2023Open Access
Supplementary Figure 1 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 4 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 3 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 5 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Data from Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action
2023Open Access
Supplementary Table 2 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
Supplementary Figure 4 from Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Paul W.H.I. Parren(21), Janine Schuurman(10), Frank J. Beurskens(9), Wim K. Bleeker(8), P J Capel(6), Tom Vink(5), J. Sjef Verbeek(5), Marjolein van Egmond(5), Annemiek B. van Spriel(5), Jeroen J. Lammerts van Bueren(5), Matthias Peipp(4), Thomas Valerius(4), Margaret A. Lindorfer(4), Ronald P. Taylor(4), Frans M.A. Hofhuis(4), Takashi Saito(4), Michael Dechant(4), Rob C. Aalberse(3), Jessica L. Teeling(3), Marc Jansen(3)